Boulder's Inscripta, a gene-editing technology firm, has acquired California-based Solana Biosciences, according to a company news release.

"The addition of the Solana team brings world-class scientific product development, manufacturing, and operations experience to further enable Inscripta to provide the best gene-editing tools to both commercial and academic researchers," Inscripta CEO Kevin Ness said in a statement.

Terms of the acquisition were not disclosed.

Solana cofounder Tom Rosso will become vice president of operations at Inscripta and will lead the process development, technology transfer, manufacturing, and operations teams at the company, the release said. Inscripta will also expand operations and obtain a new office in the life sciences hub of San Diego.

Lucas High: 303-684-5310, lhigh@dailycamera.com or twitter.com/lucashigh



Advertisement